New Delhi, April 28 -- Shares of Cohance Lifesciences extended their rally to a second straight session on Tuesday, April 28, surging as much as 17% intraday after jumping 20% in the previous session.

The stock, which had hit its upper circuit limit at Rs.432.10 on the NSE on Monday, has now gained about 37% over the past two sessions. The sharp rally follows the company's announcement appointing former Cipla CEO Umang Vohra as Executive Chairman and Group CEO.

On Tuesday, the stock opened at Rs.444.45, higher than the previous close of Rs.432.10, and climbed to an intraday high of Rs.514.65.

In an exchange filing dated 27 April, Cohance Lifesciences announced former Cipla CEO Umang Vohra as the new Executive Chairman, effective May 1 ...